AstraZeneca’s Diabetes Drug Farxiga Lowers Death Risk in Heart Failure

(Bloomberg) -- AstraZeneca Plc’s Farxiga helped stave off death in a study of patients with heart failure, opening the door to a new use for the diabetes treatment.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.